Stay updated on Nivolumab vs Docetaxel in Squamous NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Docetaxel in Squamous NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Docetaxel in Squamous NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a backend/template update; the study details remain unchanged.
    Difference
    0.0%
    Check dated 2026-05-15T06:01:08.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The Chile site listing for Valparaiso was updated by removing the explicit “Región de Valparaíso” label and switching to a shorter format ("Viña del Mar, Valparaiso, Chile"). The page footer version/revision also changed from v3.5.2 to v3.5.3.
    Difference
    0.3%
    Check dated 2026-04-24T06:10:23.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:38:49.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Padua, Italy 35128 was replaced with Padova, Italy 35128 in the Italy locations section.
    Difference
    0.0%
    Check dated 2026-04-09T21:37:43.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T06:09:26.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T00:29:45.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Docetaxel in Squamous NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Docetaxel in Squamous NSCLC Clinical Trial page.